Natixis Advisors, L.P. Dr Reddys Laboratories LTD Transaction History
Natixis Advisors, L.P.
- $63 Billion
- Q2 2025
A detailed history of Natixis Advisors, L.P. transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Natixis Advisors, L.P. holds 21,408 shares of RDY stock, worth $300,354. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,408
Previous 26,692
19.8%
Holding current value
$300,354
Previous $352,000
8.52%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding RDY
# of Institutions
261Shares Held
92.4MCall Options Held
0Put Options Held
0-
Robeco Institutional Asset Management B.V.12.2MShares$171 Million0.3% of portfolio
-
Royal Bank Of Canada Toronto, A69.96MShares$140 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny9.01MShares$126 Million0.19% of portfolio
-
Aikya Investment Management LTD London, X06.35MShares$89.2 Million28.64% of portfolio
-
Dimensional Fund Advisors LP Austin, TX5.4MShares$75.8 Million0.02% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $2.33B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...